Photons, Protons, SBRT, Brachytherapy-What Is Leading the Charge for the Management of Prostate Cancer? A Perspective From the GU Editorial Team

被引：4
作者：
Choudhury, Ananya [1 ,2 ,3 ]
Henry, Ann [4 ,5 ]
Mitin, Timur [6 ]
Chen, Ronald [7 ]
Joseph, Nuradh [8 ,9 ]
Spratt, Daniel E. [10 ]
机构：
[1] Christie NHS Fdn Trust, Dept Clin Oncol, Manchester, Lancs, England
[2] Univ Manchester, Div Canc Sci, Manchester, Lancs, England
[3] Christie NHS Fdn Trust, Manchester, Lancs, England
[4] Leeds Teaching Hosp NHS Trust, Dept Clin Oncol, Leeds, W Yorkshire, England
[5] Univ Leeds, Leeds, W Yorkshire, England
[6] Oregon Hlth & Sci Univ, Knight Canc Inst, Dept Radiat Med, Portland, OR 97201 USA
[7] Univ Kansas, Dept Radiat Oncol, Kansas City, KS USA
[8] Gen Hosp Chilaw, Minist Hlth, Colombo, Sri Lanka
[9] Sri Lanka Canc Res Grp, Colombo, Sri Lanka
[10] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2021年 / 110卷 / 04期
关键词：
DOSE-RATE BRACHYTHERAPY; EXTERNAL-BEAM RADIATION; RANDOMIZED-TRIAL; ANDROGEN SUPPRESSION; ASCENDE-RT; RADIOTHERAPY; THERAPY; BOOST; TOXICITY; PATTERNS;
D O I：
10.1016/j.ijrobp.2021.01.003
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1114 / 1121
页数：8
相关论文
共 45 条
  • [1] Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial
    Aluwini, Shafak
    Pos, Floris
    Schimmel, Erik
    Krol, Stijn
    van der Toorn, Peter Paul
    de Jager, Hanja
    Alemayehu, Wendimagegn Ghidey
    Heemsbergen, Wilma
    Heijmen, Ben
    Incrocci, Luca
    [J]. LANCET ONCOLOGY, 2016, 17 (04) : 464 - 474
  • [2] Will SBRT replace conventional radiotherapy in patients with low-intermediate risk prostate cancer? A review
    Arcangeli, Stefano
    Scorsetti, Marta
    Alongi, Filippo
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 84 (01) : 101 - 108
  • [3] Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19
    Arshad, Samia
    Kilgore, Paul
    Chaudhry, Zohra S.
    Jacobsen, Gordon
    Wang, Dee Dee
    Huitsing, Kylie
    Brar, Indira
    Alangaden, George J.
    Ramesh, Mayur S.
    McKinnon, John E.
    O'Neill, William
    Zervos, Marcus
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 97 : 396 - 403
  • [4] Exposure to direct-to-consumer advertising is associated with overestimation of benefits regarding ultrahypofractionated radiation therapy for prostate cancer
    Caputo, Joseph M.
    Lee, Henry J.
    Chiles, Bennett
    Hyams, Elias S.
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2020, 23 (04) : 670 - 679
  • [5] Brachytherapy for Patients With Prostate Cancer: American Society of Clinical Oncology/Cancer Care Ontario Joint Guideline Update
    Chin, Joseph
    Rumble, R. Bryan
    Kollmeier, Marisa
    Heath, Elisabeth
    Efstathiou, Jason
    Dorff, Tanya
    Berman, Barry
    Feifer, Andrew
    Jacques, Arthur
    Loblaw, D. Andrew
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (15) : 1737 - +
  • [6] ProtecTing Low-Risk Prostate Cancer
    Choudhury, Ananya
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (03): : 515 - 517
  • [7] Is prostate brachytherapy a dying art? Trends and variation in the definitive management of prostate cancer in Ontario, Canada
    Corkum, Mark T.
    Morton, Gerard
    Louie, Alexander, V
    Bauman, Glenn S.
    Mendez, Lucas C.
    Chin, Joseph
    D'Souza, David P.
    Dinniwell, Robert E.
    Velker, Vikram M.
    Saskin, Refik
    Warner, Andrew
    Rodrigues, George B.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2020, 152 : 42 - 48
  • [8] Time-driven activity-based cost comparison of prostate cancer brachytherapy and intensity-modulated radiation therapy
    Dutta, Sunil W.
    Bauer-Nilsen, Kristine
    Sanders, Jason C.
    Trifiletti, Daniel M.
    Libby, Bruce
    Lash, Donna H.
    Lain, Melody
    Christodoulou, Deborah
    Hodge, Constance
    Showalter, Timothy N.
    [J]. BRACHYTHERAPY, 2018, 17 (03) : 556 - 563
  • [9] Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
    Ferlay, J.
    Colombet, M.
    Soerjomataram, I.
    Mathers, C.
    Parkin, D. M.
    Pineros, M.
    Znaor, A.
    Bray, F.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (08) : 1941 - 1953
  • [10] Biochemical Control and Toxicity Outcomes of Stereotactic Body Radiation Therapy Versus Low-Dose-Rate Brachytherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer
    Gogineni, Emile
    Rana, Zaker
    Soberman, Danielle
    Sidiqi, Baho
    D'Andrea, Vincent
    Lee, Lucille
    Potters, Louis
    Parashar, Bhupesh
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 109 (05): : 1232 - 1242
12345